Back to School: How biopharma can reboot drug development. Access exclusive analysis here

sanofi-aventis reports earnings

sanofi-aventis (Euronext:SAN; SNY) reported pro forma earnings as a consolidated group

Read the full 117 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE